Impact of mycophenolic acid on the functionality of human polymorphonuclear neutrophils and dendritic cells during interaction with Aspergillus fumigatus

Antimicrob Agents Chemother. 2008 Jul;52(7):2644-6. doi: 10.1128/AAC.01618-07. Epub 2008 Apr 21.

Abstract

Mycophenolic acid (MPA) is used clinically to prevent graft rejection but may increase the risk of fungal infection. We observed that MPA enhanced the Aspergillus fumigatus-induced oxidative burst of polymorphonuclear neutrophils, but without a corresponding increase in fungal killing. Furthermore, MPA inhibited the proinflammatory cytokine response and maturation of dendritic cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aspergillus fumigatus / drug effects*
  • Aspergillus fumigatus / pathogenicity
  • Cell Differentiation / drug effects
  • Cytokines / biosynthesis
  • Dendritic Cells / cytology
  • Dendritic Cells / drug effects*
  • Dendritic Cells / immunology
  • Dendritic Cells / microbiology
  • Graft Rejection / prevention & control
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • In Vitro Techniques
  • Inflammation Mediators / metabolism
  • Mycophenolic Acid / adverse effects*
  • Neutrophils / cytology
  • Neutrophils / drug effects*
  • Neutrophils / immunology
  • Neutrophils / microbiology
  • Respiratory Burst / drug effects

Substances

  • Cytokines
  • Immunosuppressive Agents
  • Inflammation Mediators
  • Mycophenolic Acid